Omegia Softgel Clinical Research Program

Chia Nan University of Pharmacy ＆ Science

Status: Completed

Conditions: Antioxidative Stress; Eye Strain; Skin Manifestations; Vaginal Disease

Treatments: Dietary Supplement: Omegia® Softgel -A; Dietary Supplement: Omegia® Softgel -B

Study type: Interventional

Funder types: Other

Identifiers

NCT05872178

TSMHIRB-2-029-2.2

Details and patient eligibility

About

Evaluate the improvement of regulation of skin and blood index composition after consumption of Omegia® Softgel

Full description

The blood biochemical analysis at Weeks 0 and 12, including Catalase, Tumor necrosis factor-α, Cholesterol, Triglyceride, High-density lipoprotein-Cholesterol and Low-density lipoprotein- Cholesterol.

The Skin assessment at Weeks 0, 4 and 12, including Skin brightness, Skin redness sensitivity index, Skin moisture, Skin elasticity, Facial skin pores, Facial skin texture and Skin collagen content.

Enrollment: 40 patients

Sex: Female

Ages: 45 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

● Female subjects older than 45 years

Exclusion criteria

• Involuntary subjects
• Skin disease, liver cirrhosis or chronic renal failure
• Those with known cosmetic, drug or food allergies
• Pregnant women and nursing mothers.
• Those taking chronic disease medication
• The subject has received laser facial treatment, fruit acid facial peeling, long-term sunlight, etc. within four weeks of the test

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

40 participants in 2 patient groups, including a placebo group

Omegia® Softgel -A

Placebo Comparator group

Description:

Take Omegia® Softgel -A once a day for 12 weeks

Treatment:

Dietary Supplement: Omegia® Softgel -A

Omegia® Softgel -B

Experimental group

Description:

Take Omegia® Softgel-B once a day for 12 weeks

Treatment:

Dietary Supplement: Omegia® Softgel -B